Most specific marker for prostate cancer:
The main ones I remember are PSA (Prostate-Specific Antigen) and maybe Prostate-Specific Membrane Antigen (PSMA). But wait, PSA is the most common one used clinically. However, PSA isn't entirely specific because it can be elevated in benign conditions like BPH or prostatitis. So maybe the question is looking for a more specific marker than PSA.
Wait, PSMA is a transmembrane protein that's overexpressed in prostate cancer cells. It's used in imaging techniques like PSMA PET scans. PSMA might be more specific than PSA because it's not just a serum marker but a target for imaging. But I need to confirm if PSMA is considered the most specific. Alternatively, there's kallikrein-related peptidase 3 (KLK3) which is another name for PSA.
Wait, the options weren't provided, but the correct answer is supposed to be filled in. Let me check standard sources. In medical literature, PSA is the primary marker, but its specificity is low. PSMA is more specific for prostate cancer cells. So if the question is about the most specific marker, PSMA might be the answer. However, sometimes questions might consider PSA as the answer even though it's not perfect. But given the options, if one of them is PSMA, that's the correct answer.
So the core concept here is tumor markers for prostate cancer. The correct answer is PSMA because it's more specific than PSA. The other options like PSA would be incorrect because they are less specific. The clinical pearl is that PSMA is used in advanced imaging for better detection. Need to structure this into the required sections with the given format. Make sure each section is concise and within the character limit.
**Core Concept**
The question tests knowledge of tumor markers in prostate cancer. **Prostate-specific membrane antigen (PSMA)** is the most specific biomarker for prostate cancer, particularly in advanced stages, due to its overexpression in malignant versus benign prostatic tissue. **PSA (prostate-specific antigen)** is commonly used but lacks specificity for malignancy.
**Why the Correct Answer is Right**
**PSMA** is a transmembrane glycoprotein highly expressed in prostate cancer cells, especially in metastatic and castration-resistant forms. It is not detectable in normal prostate tissue or benign conditions like BPH, making it more specific than PSA. PSMA is utilized in **PSMA PET/CT imaging** for precise tumor localization and staging, offering high diagnostic accuracy.
**Why Each Wrong Option is Incorrect**
**Option A:** If "PSA" is listed, it is incorrect because PSA elevates in benign conditions (e.g., BPH, prostatitis) and lacks prostate cancer specificity.
**Option B:** If "Prostatic acid phosphatase" is listed, it is outdated and rarely used in modern practice.
**Option C:** If "Alpha-fetoprotein" is listed, it is a marker for hepatocellular carcinoma and germ cell tumors, unrelated to prostate cancer.
**Option D:** If "CA-125" is listed